Certified by Founder Lodge 
                                        
                                        Beta Bionics
 
                                                 United States  -  Irvine, CA 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $100,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2015
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Beta Bionics is a medical technology company focused on the design, development, and commercialization of the iLet Bionic Pancreas and the bihormonal configuration. The iLet is the first and 
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| September, 04 ,2023 | Series D | $100,000,000 | 
                                                
 Pura Vida Investments
                                                                                
 Omega Funds
                                                                                
 Sands Capital
                                                                                
 Perceptive Advisors
                                                                                
 Marshall Wace
                                                                                
                                                                            
 RTW Investments, LP
                                                                                
 Eventide Asset Management
                                                                                
 Farallon Capital Management
                                                                                
 ArrowMark Partners
                                                                                
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)